EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High prevalence of vaccine‐preventable anal human papillomavirus infections is associated with HIV infection among gay, bisexual, and men who have sex with men in Nairobi, Kenya

Myo Minn Oo iD, Samantha Moore, Suzanne Gibbons, Wendy Adhiambo, Peter Muthoga, Naomi Siele, Maureen Akolo, Henok Gebrebrhan, Aida Sivro, Blake T Ball, Robert R Lorway, Alberto Severini und 2 weitere

Cancer Medicine · 2023

DOI: 10.1002/cam4.6008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Myo Minn Oo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: Papillomavirus Infections, HIV Infections, Sexual and Gender Minorities, Papillomavirus Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human papillomavirus (HPV) infection is associated with anal cancers and is more prevalent in gay, bisexual, and men who have sex with men (gbMSM), partly due to their vulnerability to HIV infection. Baseline HPV genotype distributions and risk factors can inform the design of next‐generation HPV vaccines to prevent anal cancer.

Methods

A cross‐sectional study was conducted among gbMSM receiving care at a HIV/STI clinic in Nairobi, Kenya. Anal swabs were genotyped using a Luminex microsphere array. Multiple logistic regression methods were used to identify risk factors for four HPV outcomes (any HPV, any HR‐HPV, and 4‐ and 9‐valent vaccine‐preventable HPVs).

Results

Among 115 gbMSM, 51 (44.3%) were HIV‐infected. Overall HPV prevalence was 51.3%; 84.3% among gbMSM living with HIV and 24.6% among gbMSM without HIV ( p < 0.001). One‐third (32.2%) had HR‐HPV and the most prevalent vaccine‐preventable HR‐HPV genotypes were 16, 35, 45, and 58. HPV‐18 was uncommon ( n = 2). The 9‐valent Gardasil vaccine would have prevented 61.0% of HPV types observed in this population. In multivariate analyses, HIV status was the only significant risk factor for any HPV (adjusted odds ratio [aOR]:23.0, 95% confidence interval [95% CI]: 7.3–86.0, p < 0.001) and for HR‐HPV (aOR: 8.9, 95% CI: 2.8–36.0, p < 0.001). Similar findings were obtained for vaccine‐preventable HPVs. Being married to a woman significantly increased the odds of having HR‐HPV infections (aOR: 8.1, 95% CI: 1.6–52.0, p = 0.016).

Conclusions

GbMSM living with HIV in Kenya are at higher risk of anal HPV infections including genotypes that are preventable with available vaccines. Our findings support the need for a targeted HPV vaccination campaign in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHIV InfectionsSexual and Gender MinoritiesPapillomavirus VaccinesAnus DiseasesHuman Papillomavirus VirusesPrevalenceHumansMaleCross-Sectional StudiesKenyaYoung AdultAdultGenotype

Stichwörter der Autor:innen

HIV/STIHPV genotypesHPV vaccinationKenyaanal HPVbisexualgay and men who have sex with men (gbMSM)

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Institute for Global Public Health (IGPH), University of Manitoba, Winnipeg, Manitoba, Canada.
  • JC Wilt Infectious Disease Research Centre, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • University of Nairobi Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
  • Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa.
  • Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.

ORCID-Profile: Myo Minn Oo

Zitieren

APA

Oo, M. M., Moore, S., Gibbons, S., Adhiambo, W., Muthoga, P., Siele, N., Akolo, M., Gebrebrhan, H., Sivro, A., Ball, B. T., Lorway, R. R., Severini, A., Kimani, J., & McKinnon, L. R. (2023). High prevalence of vaccine‐preventable anal human papillomavirus infections is associated with HIV infection among gay, bisexual, and men who have sex with men in Nairobi, Kenya. Cancer Medicine. https://doi.org/10.1002/cam4.6008

Vancouver

Oo MM, Moore S, Gibbons S, Adhiambo W, Muthoga P, Siele N, et al. High prevalence of vaccine‐preventable anal human papillomavirus infections is associated with HIV infection among gay, bisexual, and men who have sex with men in Nairobi, Kenya. Cancer Medicine. 2023. doi:10.1002/cam4.6008

BibTeX
@article{Oo2023,
  author = {Oo, Myo Minn and Moore, Samantha and Gibbons, Suzanne and Adhiambo, Wendy and Muthoga, Peter and Siele, Naomi and Akolo, Maureen and Gebrebrhan, Henok and Sivro, Aida and Ball, Blake T and Lorway, Robert R and Severini, Alberto and Kimani, Joshua and McKinnon, Lyle R},
  title = {High prevalence of vaccine‐preventable anal human papillomavirus infections is associated with HIV infection among gay, bisexual, and men who have sex with men in Nairobi, Kenya},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6008}
}
Kostenlos starten →